ctrl-trade
All companies

JNJ vs LLY

Johnson & Johnson and Eli Lilly and Company, side by side.

Johnson & Johnson
JNJ Drug Manufacturers - General

Johnson & Johnson

$230.80 on May 29, 2026
View full JNJ profile →
Eli Lilly and Company
LLY Drug Manufacturers - General

Eli Lilly and Company

$1,126.80 on May 29, 2026
View full LLY profile →

Figures reflect each company's latest snapshot — no metric is a verdict on its own. New to these numbers? Learn how to read them →

Company Size

How large is this company relative to the overall market?

Metric JNJ LLY

Company Size

$555.59B · Mega-cap

$1.00T · Mega-cap

Valuation

Is this stock priced cheaply or expensively relative to its earnings and revenue?

Metric JNJ LLY

P/E Ratio

26.7x

40.0x

Forward P/E

18.2x

25.3x

Price-to-Sales

5.8x

13.9x

Profitability

How efficiently does the company turn revenue into profit?

Metric JNJ LLY

Profit Margin

21.8%

35.0%

Gross Margin

68.0%

82.8%

Return on Equity

26.4%

107.5%

Growth

Is the business expanding — or contracting?

Metric JNJ LLY

Revenue Growth

9.9%

55.5%

Earnings Growth

-52.9%

169.9%

Financial Health

Can the company handle its debts and short-term obligations?

Metric JNJ LLY

Debt-to-Equity

0.68x

1.39x

Current Ratio

1.02x

1.50x

Dividends

Does the company pay shareholders regular cash income?

Metric JNJ LLY

Dividend Yield

2.2%

0.6%

Risk & Volatility

How much does this stock move relative to the overall market?

Metric JNJ LLY

Volatility (Beta)

0.26x

0.48x

Analyst View

What do professional Wall Street analysts say about this stock?

Metric JNJ LLY

Analyst Consensus

Buy (24 analysts)

Buy (29 analysts)

Analyst Target Price

$252.96

+9.6% vs price

$1215.10

+7.8% vs price
Early access

Research done. Time to trade.

Ctrl-Trade is the options trading app built for beginners who want to trade like pros — find opportunities, manage positions with ease, and stay profitable.

No spam. Unsubscribe any time.